These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38320799)

  • 1. [Research progress of non-coding RNA-encoding polypeptides in primary hepatocellular carcinoma].
    Chen DM; Yu Z; Zhang ZW; Huang JL
    Zhonghua Gan Zang Bing Za Zhi; 2024 Jan; 32(1):91-96. PubMed ID: 38320799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel insights into small open reading frame-encoded micropeptides in hepatocellular carcinoma: A potential breakthrough.
    Zhang Q; Liu L
    Cancer Lett; 2024 Apr; 587():216691. PubMed ID: 38360139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.
    Xue C; Gu X; Bao Z; Su Y; Lu J; Li L
    Front Immunol; 2022; 13():847728. PubMed ID: 35281015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
    George J; Patel T
    Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects of Noncoding RNAs in Hepatocellular Carcinoma.
    Zhou H; Xu Q; Ni C; Ye S; Xu X; Hu X; Jiang J; Hong Y; Huang D; Yang L
    Biomed Res Int; 2018; 2018():6579436. PubMed ID: 30148169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.
    Heo MJ; Yun J; Kim SG
    Arch Pharm Res; 2019 Jan; 42(1):48-62. PubMed ID: 30610616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CLINICAL SIGNIFICANCE OF NONCODING RNA IN HEPATOCELLULAR CARCINOMA].
    Eguchi H; Doki Y; Mori M
    Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):366-9. PubMed ID: 26845888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.
    Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X
    Front Immunol; 2022; 13():985815. PubMed ID: 36300115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-related micropeptides encoded by ncRNAs: Promising drug targets and prognostic biomarkers.
    Setrerrahmane S; Li M; Zoghbi A; Lv X; Zhang S; Zhao W; Lu J; Craik DJ; Xu H
    Cancer Lett; 2022 Oct; 547():215723. PubMed ID: 35533953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.
    Liao W; Du J; Wang Z; Feng Q; Liao M; Liu H; Yuan K; Zeng Y
    Int J Cancer; 2022 Aug; 151(3):337-347. PubMed ID: 35460073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting non-coding RNAs and N
    Wu L; Zhang Y; Ren J
    Biochem Pharmacol; 2024 May; 223():116153. PubMed ID: 38513741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide SMIM30 promotes HCC development by inducing SRC/YES1 membrane anchoring and MAPK pathway activation.
    Pang Y; Liu Z; Han H; Wang B; Li W; Mao C; Liu S
    J Hepatol; 2020 Nov; 73(5):1155-1169. PubMed ID: 32461121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular localization and relevant mechanisms of human cancer-related micropeptides.
    Deng J; Xu W; Jie Y; Chong Y
    FASEB J; 2023 Dec; 37(12):e23270. PubMed ID: 37994683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma.
    Tan C; Cao J; Chen L; Xi X; Wang S; Zhu Y; Yang L; Ma L; Wang D; Yin J; Zhang T; John Lu Z
    Clin Chem; 2019 Jul; 65(7):905-915. PubMed ID: 30996051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress on sORF-encoded micropeptides].
    Chen XY; Li MW; Wang Y; Chen Q; Xu HM
    Yi Chuan; 2021 Aug; 43(8):737-746. PubMed ID: 34413014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome.
    Afra F; Mahboobipour AA; Salehi Farid A; Ala M
    Biomed Pharmacother; 2023 Sep; 165():115104. PubMed ID: 37393866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncoding RNAs (ncRNA) in Hepato Cancer: A Review.
    Sun X; Malhotra A
    J Environ Pathol Toxicol Oncol; 2018; 37(1):15-25. PubMed ID: 29772997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
    Wong CM; Tsang FH; Ng IO
    Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.
    Fang Y; Zhang X; Huang H; Zeng Z
    J Transl Med; 2023 Jun; 21(1):369. PubMed ID: 37286982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.